Clinical Study of Rituximab for the Treatment for Idiopathic Membranous Nephropathy With Nephrotic Syndrome
Clinical trial NCT05914155 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05914155
- Sponsor
- Shoichi Maruyama MD PhD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-24
- Primary completion
- 2028-06-30
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.